Pfizer Czech Republic made a net profit of CZK 103 mil with revenues of CZK 3,586 mil in 2017, up by 39.7% and up by 10.6%, respectively, compared to the previous year.
This translates into a net margin of 2.86%. Historically, between 2002 and 2017, the firm’s net margin reached a high of 7.17% in 2003 and a low of -30.0% in 2002. The average net margin in the last five years amounted to 2.58%.
On the operating level, the EBITDA margin reached 4.36% and EBIT amounted to 3.68% of sales in 2017.
You can see all the company’s data at Pfizer Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
